Inclusion Criteria:  Subjects who have received 4 doses of experimental vaccine or control vaccine in phase Ⅲ clinical trials  Exclusion Criteria:  History of vaccination of other vaccine with poliovirus antigenic components except that of phaseⅢ clinical trial.